A new vasculitis activity score for predicting death in myeloperoxidase-antineutrophil cytoplasmic antibody-associated vasculitis patients

American Journal of Nephrology

Volumn 35, Issue 1, 2012, Pages 1-6

  Koike, Kiyomi ^a   Fukami, Kei ^a   Yonemoto, Koji ^a   Iwatani, Ryuji ^a   Obata, Rimi ^a   Ueda, Kaoru ^a   Toyonaga, Maki ^a   Ueda, Seiji ^a   Ohara, Atsuko ^a   Takeda, Kazuhito ^a   Yamagishi, Sho Ichi ^a   Okuda, Seiya ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Birmingham Vasculitis Activity Score; Japanese Vasculitis Activity Score; Mortality rate; Myeloperoxidase antineutrophil cytoplasmic antibody; Odds ratio; Receiver operating characteristic

Indexed keywords

CORTICOSTEROID; CYCLOPHOSPHAMIDE; METHYLPREDNISOLONE; MYELOPEROXIDASE; NEUTROPHIL CYTOPLASMIC ANTIBODY;

ADULT; AGED; ANCA ASSOCIATED VASCULITIS; AREA UNDER THE CURVE; ARTICLE; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE COURSE; ENZYME ACTIVITY; FEMALE; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; PREDICTION; PREDICTIVE VALIDITY; PRIORITY JOURNAL; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC; RELIABILITY; RETROSPECTIVE STUDY; RISK; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; STATISTICAL SIGNIFICANCE; UNIVARIATE ANALYSIS;

AGED; ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS; CARDIOLOGY; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; MODELS, STATISTICAL; ODDS RATIO; PEROXIDASE; RETROSPECTIVE STUDIES; ROC CURVE; SENSITIVITY AND SPECIFICITY; TIME FACTORS; TREATMENT OUTCOME; VASCULITIS;

EID: 82355181640     PISSN: 02508095     EISSN: 14219670     Source Type: Journal    
DOI: 10.1159/000334357     Document Type: Article

References (25)

1. Kallenberg CG: Pathogenesis of ANCA-associated vasculitides. Ann Rheum Dis 2011; 70(suppl 1):i59-i63.
2. Wilde B, van Paassen P, Witzke O, Tervaert JW: New pathophysiological insights and treatment of ANCA-associated vasculitis. Kidney Int 2011; 79: 599-612.
3. Jennette JC: Nomenclature and classification of vasculitis: lessons learned from granulomatosis with polyangiitis (Wegener's granulomatosis). Clin Exp Immunol 2011; 164 (suppl 1):7-10.
4. Kallenberg CG: Pathophysiology of ANCAassociated small vessel vasculitis. Curr Rheumatol Rep 2010; 12: 399-405.
5. Chen M, Kallenberg CG: New advances in the pathogenesis of ANCA-associated vasculitides. Clin Exp Rheumatol 2009; 27: S108-S114.
6. Kallenberg CG: Pathogenesis of PR3-ANCA associated vasculitis. J Autoimmun 2008; 30: 29-36.
7. Xu P, Chen M, Cui Z, Zhao M: Influence of myeloperoxidase by anti-myeloperoxidase antibodies and its association with the disease activity in microscopic polyangiitis. Rheumatology (Oxford) 2010; 49: 2068-2075.
8. Koyama A, Yamagata K, Makino H, Arimura Y, Wada T, Nitta K, Nihei H, Muso E, Taguma Y, Shigematsu H, Sakai H, Tomino Y, Matsuo S, Group JRR: A nationwide survey of rapidly progressive glomerulonephritis in Japan: etiology, prognosis and treatment diversity. Clin Exp Nephrol 2009; 13: 633-650.
9. Lane S, Scott D, Heaton A, Watts R: Primary renal vasculitis in Norfolk - increasing incidence or increasing recognition? Nephrol Dial Transplant 2000; 15: 23-27. (Pubitemid 30037926)
10. Booth A, Almond M, Burns A, Ellis P, Gaskin G, Neild G, Plaisance M, Pusey C, Jayne D: Outcome of ANCA-associated renal vasculitis: a 5-year retrospective study. Am J Kidney Dis 2003; 41: 776-784. (Pubitemid 36396745)
11. Guillevin L, Lhote F, Gayraud M, Cohen P, Jarrousse B, Lortholary O, Thibult N, Casassus P: Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome. A prospective study in 342 patients. Medicine (Baltimore) 1996; 75: 17-28. (Pubitemid 26041085)
12. Hauer HA, Bajema IM, van Houwelingen HC, Ferrario F, Noël LH, Waldherr R, Jayne DR, Rasmussen N, Bruijn JA, Hagen EC, European Vasculitis Study Group (EUVAS): Renal histology in ANCA-associated vasculitis: differences between diagnostic and serologic subgroups. Kidney Int 2002; 61: 80-89. (Pubitemid 34075133)
13. Lane S, Watts R, Shepstone L, Scott D: Primary systemic vasculitis: clinical features and mortality. QJM 2005; 98: 97-111. (Pubitemid 40277566)
14. Weidner S, Geuss S, Hafezi-Rachti S, Wonka A, Rupprecht HD: ANCA-associated vasculitis with renal involvement: an outcome analysis. Nephrol Dial Transplant 2004; 19: 1403-1411. (Pubitemid 38786731)
15. Luqmani R, Bacon P, Moots R, Janssen B, Pall A, Emery P, Savage C, Adu D: Birmingham vasculitis activity score (BVAS) in systemic necrotizing vasculitis. QJM 1994; 87: 671-678. (Pubitemid 24334817)
16. Gayraud M, Guillevin L, le Toumelin P, Cohen P, Lhote F, Casassus P, Jarrousse B: Longterm followup of polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: analysis of four prospective trials including 278 patients. Arthritis Rheum 2001; 44: 666-675. (Pubitemid 32234626)
17. Itabashi M, Takei T, Yabuki Y, Suzuki H, Ando M, Akamatsu M, Yamazaki M, Mitobe M, Watanabe Y, Mochizuki T, Nitta K: Clinical outcome and prognosis of anti-neutrophil cytoplasmic antibody-associated vasculitis in Japan. Nephron Clin Pract 2010; 115:c21-c27.
18. Flossmann O, Berden A, de Groot K, Hagen C, Harper L, Heijl C, Höglund P, Jayne D, Luqmani R, Mahr A, Mukhtyar C, Pusey C, Rasmussen N, Stegeman C, Walsh M, Westman K, European Vasculitis Study Group: Long-term patient survival in ANCA-associated vasculitis. Ann Rheum Dis 2011; 70: 488-494.
19. Sakai H, Kurokawa K, Koyama A, Arimura Y, Kida H, Shigematsu H, Suzuki S, Nihei H, Makino H, Ueda N, Kawamura T, Gejyo F, Saito T, Harada T, Hiki Y, Yoshida M: Guidelines for the management of rapidly progressive glomerulonephritis (in Japanese). Nippon Jinzo Gakkai Shi 2002; 44: 55-82. (Pubitemid 34456622)
20. Jennette J, Falk R, Andrassy K, Bacon P, Churg J, Gross W, Hagen E, Hoffman G, Hunder G, Kallenberg C: Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 1994; 37: 187-192. (Pubitemid 24065492)
21. Jennette J, Falk R: Small-vessel vasculitis. N Engl J Med 1997; 337: 1512-1523. (Pubitemid 27495778)
22. Jayne D, Rasmussen N: Treatment of antineutrophil cytoplasm autoantibody-associated systemic vasculitis: initiatives of the European Community Systemic Vasculitis Clinical Trials Study Group. Mayo Clin Proc 1997; 72: 737-747. (Pubitemid 127758162)
23. Mahr AD, Neogi T, Lavalley MP, Davis JC, Hoffman GS, McCune WJ, Specks U, Spiera RF, St Clair EW, Stone JH, Merkel PA, Group WsGETR: Assessment of the item selection and weighting in the Birmingham vasculitis activity score for Wegener's granulomatosis. Arthritis Rheum 2008; 59: 884-891. (Pubitemid 351847573)
24. Harper L, Savage C: ANCA-associated renal vasculitis at the end of the twentieth century - a disease of older patients. Rheumatology (Oxford) 2005; 44: 495-501. (Pubitemid 41511141)
25. Little MA, Nightingale P, Verburgh CA, Hauser T, De Groot K, Savage C, Jayne D, Harper L, European Vasculitis Study (EUVAS) Group: Early mortality in systemic vasculitis: relative contribution of adverse events and active vasculitis. Ann Rheum Dis 2010; 69: 1036-1043.